Sugi Predict

Sugi Predict / Compounds / SCHEMBL291455

SCHEMBL291455

SCHEMBL291455

N#Cc1ccccc1S(N)(=O)=O

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CA2 P00918 8/20 0.58
▸ CA9 Q16790 7/20 0.58
▸ CA12 O43570 6/20 0.58
▸ ALDH1A1 P00352 1/20 0.58
▸ HTT P42858 1/20 0.58
▸ CA1 P00915 5/20 0.50
▸ CA6 P23280 3/20 0.50
▸ CA4 P22748 2/20 0.50
▸ CA5A P35218 2/20 0.50
▸ CA7 P43166 2/20 0.50
▸ CA5B Q9Y2D0 2/20 0.50
▸ CYP2C9 P11712 1/20 0.50
▸ CA14 Q9ULX7 1/20 0.50
▸ POLB P06746 1/20 0.46
▸ SLC22A12 Q96S37 2/20 0.45
▸ ALOX5 P09917 1/20 0.44
▸ PKM P14618 1/20 0.44
▸ LMNA P02545 1/20 0.43
▸ HSD11B1 P28845 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29961798 1.00 CA2 (0.58) CA2CA9CA12ALDH1A1HTT
SCHEMBL23909546 0.84 CDK2 (0.56) CA2CA9CA12ALDH1A1HTT
SCHEMBL30468568 0.82 ALDH1A1 (0.62) CA2ALDH1A1HTTCA1POLB
SCHEMBL8514629 0.82 ALDH1A1 (0.62) CA2ALDH1A1HTTCA1POLB
SCHEMBL25167721 0.80 CA2 (0.46) CA2CA9CA12ALDH1A1HTT
SCHEMBL23909578 0.80 CA2 (0.48) CA2CA9CA12ALDH1A1HTT
SCHEMBL4520419 0.80 ALDH1A1 (0.60) CA2ALDH1A1HTTCA1POLB
SCHEMBL5501971 0.80 CA2 (0.60) CA2CA9CA12ALDH1A1HTT
SCHEMBL2047783 0.80 ALDH1A1 (0.60) CA2ALDH1A1HTTCA1POLB
SCHEMBL3877411 0.78 ALDH1A1 (0.58) ALDH1A1HTTPOLBSLC22A12PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 331 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119219810-A Ionic polymer and preparation method and application thereof 佛山绿动氢能科技有限公司 2024-12-31 — — CN claimed
CN-113862708-B Method for electrochemically synthesizing beta-cyano bis-benzenesulfonimide compound 常州工学院 2023-09-01 — — CN claimed
CN-108963389-B Gelable system for lithium-air battery and preparation method and application thereof 北京师范大学 2020-11-13 — — CN claimed
EP-3637524-A1 GELATINIZED SYSTEM AND APPLICATIONS IN LITHIUM AIR BATTERY, SUPER CAPACITOR OR CAPACITOR BATTERY IN ORGANIC SYSTEM Beijing Normal University (CN) 2020-04-15 — — EP claimed
EP-3637525-A1 FLEXIBLE ALL-SOLID-STATE LITHIUM-ION SECONDARY BATTERY AND MANUFACTURING METHOD THEREFOR Beijing Normal University (CN) 2020-04-15 — — EP claimed
US-20200099090-A1 FLEXIBLE ALL-SOLID-STATE LITHIUM-ION SECONDARY BATTERY AND PREPARATION METHOD THEREOF BEIJING NORMAL UNIVERSITY (CN) 2020-03-26 — — US claimed
US-20200099097-A1 GELABLE SYSTEM AND USES THEREOF IN LITHIUM-AIR BATTERIES, ORGANIC SUPERCAPACITORS OR CAPACITOR BATTERIES BEIJING NORMAL UNIVERSITY (CN) 2020-03-26 — — US claimed
CN-109761944-A A kind of chrysin amide derivatives and preparation method thereof and medical usage 武汉翼博济生生物科技有限公司 2019-05-17 — — CN claimed
CN-108963389-A It is a kind of for lithium-air battery can gelling system and its preparation method and application 北京师范大学 2018-12-07 — — CN claimed
CN-106588742-A Pyroglutamic acid-derived hydrogen-bonding organic catalyst and its preparation method and application 中南大学 2017-04-26 — — CN claimed
EP-1670752-A1 2-CYANOBENZENESULFONAMIDES FOR COMBATING ANIMAL PESTS BASF AKTIENGESELLSCHAFT (DE) 2006-06-21 — — EP claimed
US-6977264-B2 Substituted piperidines and methods of use AMGEN INC. (US) 2005-12-20 — — US claimed
WO-2005035486-A1 2-CYANOBENZENESULFONAMIDES FOR COMBATING ANIMAL PESTS BASF AKTIENGESELLSCHAFT (DE) 2005-04-21 — — WO claimed
US-20040006067-A1 Substituted piperidines and methods of use AMGEN INC. 2004-01-08 — — US claimed
US-20030220324-A1 Substituted piperazines and methods of use AMGEN INC. 2003-11-27 — — US claimed
US-20020065271-A1 Novel sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion PEYMAN ANUSCHIRWAN (DE) 2002-05-30 — — US claimed
EP-1049677-A1 NOVEL SULFONAMIDE DERIVATIVES AS INHIBITORS OF BONE RESORPTION AND AS INHIBITORS OF CELL ADHESION Aventis Pharma Deutschland GmbH (DE) 2000-11-08 — — EP claimed
WO-1999037621-A1 NOVEL SULFONAMIDE DERIVATIVES AS INHIBITORS OF BONE RESORPTION AND AS INHIBITORS OF CELL ADHESION AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 1999-07-29 — — WO claimed
EP-0293596-B1 CORRECTION FLUID AND PROCESS FOR THE TREATMENT OF SCRATCHES ON LITHOGRAPHIC PRINTING PLATES HOECHST CELANESE CORPORATION (US) 1991-11-06 — — EP claimed
EP-0293596-A2 Correction fluid and process for the treatment of scratches on lithographic printing plates HOECHST CELANESE CORPORATION (US) 1988-12-07 — — EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030220324-A1 Substituted piperazines and methods of use MC5R, MC4R, MC1R CA2 3148/4885CA9 4438/4885CA12 3977/4885
US-20020065271-A1 Novel sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion SOST, SELPLG, BST2 CA2 667/4885CA9 1482/4885CA12 1585/4885
US-20040006067-A1 Substituted piperidines and methods of use MC4R, MC5R, MC1R CA2 3303/4885CA9 3735/4885CA12 4764/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.